Ronald Reagan UCLA Medical Center (Investigational Drug Section) — Los Angeles, California

Ronald Reagan UCLA Medical Center (Investigational Drug Section) is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Ronald Reagan UCLA Medical Center (Investigational Drug Section) has participated in 1 clinical trials.

Therapeutic areas: Duchenne Muscular Dystrophy.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ronald Reagan UCLA Medical Center (Investigational Drug Section)?

Ronald Reagan UCLA Medical Center (Investigational Drug Section) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ronald Reagan UCLA Medical Center (Investigational Drug Section) conducted?

Ronald Reagan UCLA Medical Center (Investigational Drug Section) has 1 clinical trials on record. Their work covers Duchenne Muscular Dystrophy.

Is Ronald Reagan UCLA Medical Center (Investigational Drug Section) accredited by Crixeo Health?

Ronald Reagan UCLA Medical Center (Investigational Drug Section) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ronald Reagan UCLA Medical Center (Investigational Drug Section)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.